Net Cash Provided by (Used in) Operating Activities |
-475K |
USD |
-27.1% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
474K |
USD |
+27% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-125K |
USD |
+94.5% |
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
2.28M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
711 |
USD |
-99.6% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
173K |
USD |
-70.9% |
Q4 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Gross |
173K |
USD |
-70.9% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
53K |
USD |
|
Q4 2023 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |